Stock Markets May 22, 2026 08:31 AM

Wingtech Seeks 8 Billion Yuan in Lawsuit Over Nexperia Control

Guangdong court accepts complaint as parent company says its control of Dutch chip unit remains limited after government intervention last year

By Maya Rios

Wingtech Technology and a subsidiary have filed a lawsuit in Guangdong province seeking 8 billion yuan ($1.18 billion) in compensation from Nexperia B.V. and five other entities, claiming economic losses. A Shanghai Stock Exchange filing shows a local court has accepted the case. Wingtech, which is the owner of Nexperia, said its ability to exercise control over the Netherlands-based chipmaker remains restricted following a Dutch government intervention last year.

Wingtech Seeks 8 Billion Yuan in Lawsuit Over Nexperia Control

Key Points

  • Wingtech and a subsidiary have filed a lawsuit against Nexperia B.V. and five other entities seeking 8 billion yuan in compensation for economic losses.
  • A court in Guangdong province has accepted the case, as disclosed in a filing to the Shanghai Stock Exchange.
  • Wingtech, the owner of Nexperia, reports its control over the Netherlands-based chipmaker remains restricted following a Dutch government takeover last year - an issue that affects the semiconductor sector and cross-border corporate governance.

Wingtech Technology announced on Friday that it and a wholly owned subsidiary have initiated legal action against Nexperia B.V. and five associated entities, seeking 8 billion yuan in compensation for economic losses linked to a control dispute.

According to a filing submitted to the Shanghai Stock Exchange, a court in Guangdong province has accepted the complaint. The filing states the monetary claim totals 8 billion yuan, equivalent to about $1.18 billion.

Wingtech, which holds ownership of Nexperia, told investors in the filing that its control of the Netherlands-based chipmaker continues to be restricted. The company noted the dispute traces back to last year when the Dutch government took control of Nexperia from its Chinese parent, Wingtech.

The filing does not provide further detail on the nature of the alleged economic losses or the specific remedies sought beyond the stated compensation amount. It also does not outline a timeline for the court process or indicate how long the restriction on control is expected to persist.


Context and current status

The lawsuit has been officially lodged and accepted by a Guangdong court, as confirmed by the exchange filing. Beyond that confirmation, the filing does not elaborate on procedural steps to follow or potential interim measures. Wingtech reiterates that despite its ownership, its practical control over Nexperia is limited following last year’s government action in the Netherlands.


What is known and what is not

  • The parties bringing the suit are Wingtech Technology and a subsidiary.
  • The defendants are Nexperia B.V. and five other entities; the filing names no additional defendants in the public summary.
  • The claim seeks 8 billion yuan in compensation for economic losses.
  • A Guangdong court has accepted the case, according to a Shanghai Stock Exchange filing.
  • Wingtech states its control over Nexperia remains restricted after the Dutch government took control of the chipmaker last year.

The filing does not disclose further facts such as detailed causes of the alleged losses, any steps taken by regulators or companies since the government intervention, or expected dates for hearings or judgments.

Risks

  • Uncertain legal outcome - the Guangdong court has accepted the case, but the filing provides no timeline or guaranteed remedy, creating uncertainty for the companies involved and stakeholders in the semiconductor sector.
  • Restricted control persists - Wingtech reports that its ability to exercise control over Nexperia remains limited, which may affect corporate decision-making and operational oversight in the chipmaking business.
  • Limited public detail - the filing does not specify the nature of the alleged economic losses or the procedural roadmap for the litigation, leaving investors and counterparties with incomplete information about potential future impacts.

More from Stock Markets

Toronto market ends at fresh record as healthcare, financials and materials lead gains Jun 4, 2026 After-Hours Movers: Lululemon Dips on Guidance as Software and Data Names Show Mixed Reactions Jun 4, 2026 Lululemon Lowers Fiscal 2026 Revenue and EPS Guidance as U.S. Demand Softens Jun 4, 2026 Anthropic Places Engineers Inside NSA to Support Mythos AI for Offensive Cyber Tasks Jun 4, 2026 Trump Directs $700M Toward Coal Industry, Lifting Peabody Shares Jun 4, 2026